apomorphine has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iinuma, KM; Imamura, T; Kira, JI; Murai, H; Nakamura, N; Ohyagi, Y; Soejima, N; Yamasaki, R; Yanagihara, YT | 1 |
| Andel, M; Brunerova, L; Horacek, J; Potockova, J; Suchy, J | 1 |
1 trial(s) available for apomorphine and Insulin Resistance
| Article | Year |
|---|---|
Central dopaminergic activity influences metabolic parameters in healthy men.
Topics: Adult; Apomorphine; Blood Glucose; Body Mass Index; Central Nervous System; Dopamine; Dopamine Agonists; Dopaminergic Neurons; Energy Metabolism; Health; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 2013 |
1 other study(ies) available for apomorphine and Insulin Resistance
| Article | Year |
|---|---|
Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apomorphine; Disease Models, Animal; Dopamine Agonists; Exploratory Behavior; Gene Expression Regulation; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulysin; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phosphorylation; Presenilin-1 | 2017 |